Actively Recruiting
Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations
Led by Boston VA Research Institute, Inc. · Updated on 2025-09-18
104
Participants Needed
1
Research Sites
226 weeks
Total Duration
On this page
Sponsors
B
Boston VA Research Institute, Inc.
Lead Sponsor
M
Mclean Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Neurofeedback intervention aimed to regulate the superior temporal gyrus (STG) activation and default mode network (DMN) connectivity as well as to reduce the auditory hallucinations (AH) schizophrenia patients with medication resistant AH.
CONDITIONS
Official Title
Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with schizophrenia or schizoaffective disorder using DSM-5 criteria
- Auditory hallucinations not responsive to medication as confirmed by chart review and clinical interview
You will not qualify if you...
- Neurologic illness
- Major head trauma
- Electroconvulsive therapy
- Alcohol or drug dependence
- Alcohol or drug abuse within the past five years
- Verbal IQ below 70
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Boston VA Healthcare System, Brockton
Brockton, Massachusetts, United States, 02301
Actively Recruiting
Research Team
M
margaret niznikiewicz, PhD
CONTACT
C
Clemens Bauer, phd
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here